Indiana Trial Court Denies Class Certification for OxyContin® Plaintiffs

LEBANON, Ind. - An Indiana trial court has denied certification to a putative class of plaintiffs alleging addiction and other injury from Purdue Pharma's OxyContin pain medication. Johnson v. Abbott Laboratories, No. 06C01-0203-PL-89 (Ind. Cir. Ct., Boone Cty.).

Boone County Circuit Judge Steve David concluded on Dec. 31that Sandra Alvarez and two co-plaintiffs failed to demonstrate that a class action would be preferable to individual actions, or that class members could meet typicality, numerosity or other criteria for certification under Indiana Trial Rule 23.

The Alvarez plaintiffs allege that Purdue Pharma and OxyContin co-marketer Abbott Laboratories engaged in unfair and …